Long term contracts in the global medical market with reoccurring revenues.
The right management now in place
Plus an FDA approval waiting to be acted on.
I would suggest at the currnet share price this is a bloody standout investment.
Ann: Q1 Quarterly Activity Report & Appendix 4C, page-2
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.005(1.12%) |
Mkt cap ! $20.49M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 45.0¢ | $11.54K | 25.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 2549 | 1 |
View Market Depth
| Last trade - 15.34pm 27/06/2024 (20 minute delay) ? |
| IME (ASX) Chart |